Patient info Open main menu

Phenylephrine 0.1 mg/ml, solution for injection – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine strength:
0.1 mg/ml
Contains active substance:

Patient leaflet - Phenylephrine 0.1 mg/ml, solution for injection

1. What Phenylephrine is and what it is used for

This drug belongs to a group called adrenergic or dopaminergic agents. Phenylephrine is used to treat low blood pressure that can occur during different types of anesthesia.

2. What you need to know before you use Phenylephrine

Do not use Phenylephrine if:

  • you are allergic (hypersensitive) to phenylephrine or any of the other ingredients of this medicine (listed in section 6).
  • you suffer from hypertension (increased blood pressure)
  • you are suffering from a peripheral vascular disease (poor blood circulation)
  • you take a non-selective monoamine oxidase inhibitor (MAO) (or within 2 weeks of their withdrawal) for treatment of depression (iproniazide, nialamide).
  • you suffer from a severe overactive thyroid gland (hyperthyroidism)

Warnings and precautions

Talk to your doctor, pharmacist or nurse before using Phenylephrine; - if you are elderly

  • if you have an overactive thyroid gland
  • if you suffer from heart problems as a slow pulse, heart block (partial), heart muscle disease, poor blood circulation in the heart, non-severe peripheral vascular insufficiency, heart rhythm disorders, tachycardia (high heart rate), bradycardia (low heart rate), angina pectoris
  • if you have poor blood circulation in the brain
  • if you have atherosclerosis (hardening and thickening of the blood vessel walls)
  • if you have diabetes mellitus
  • if you are treated with oxytocin as the effect on the blood vessels can be enhanced and cause very high blood pressure and stroke in the period immediately after childbirth
  • if you suffer from arterial hypertension
  • if you suffer from a closed angle glaucoma

In patients with serious heart failure phenylephrine may worsen the heart failure as a consequence of blood vessel constriction.

The blood pressure in your arteries will be monitored during treatment. If you have heart disease, additional monitoring of vital functions will be performed.

Children

The medicine is not recommended for use in children due to insufficient data on efficacy, safety and dosage recommendations.

Other medicines and Phenylephrine

Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.

Do not use Phenylephrine with:

  • iproniazide, nialamide (for depression)

The following medicines may affect or be affected by concomitant use:

  • dihydroergotamine, ergotamine, methylergometrine, methysergide (for migraine) - linezolid (an antibiotic)
  • bromocriptine, cabergoline, lisuride, pergolide (for Parkinson's disease)
  • desipramine, imipramine, nortriptyline, moclobemide, toloxatone, minalcipram, venlafaxine (for depression)
  • anaesthetics that are inhaled (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane)
  • medicine used to treat high blood pressure (guanethidine)
  • medicines used to treat heart failure and certain irregular heartbeats (cardiac glycosides) - medicine used to treat abnormal heart rhythm (quinidine) - medicine used during labour (oxytocin).

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, pharmacist or nurse for advice before taking this medicine.

Pregnancy

This medication should not be used during pregnancy unless absolutely necessary.

Breast-feeding

This medication should not be used during breast-feeding unless it is absolutely necessary. However, in the event of a single administration during childbirth, breast-feeding is possible.

Driving and using machines

Not relevant.

Phenylephrine contains sodium

  • Each 10 ml ampoule contains 1.6 mmol (36.8 mg) sodium. This is equivalent to 1,8% of the recommended maximum daily intake of sodium for an adult.
  • Each 5 ml ampoule contains 0.8 mmol (18.4 mg) sodium per dose. This means that it contains less than 1 mmol sodium (23 mg), that is to say essentially “sodium-free”.

3. How to take Phenylephrine

The administration will be performed by a health-care professional with appropriate training and relevant experience.

Use in Adults

Your doctor or nurse will give you Phenylephrine into a vein (intravenously). Your doctor will decide the right dose for you and when and how it should be injected.

Use in patients with impaired renal function

Lower doses of phenylephrine may be needed in patients with impaired renal function.

Use in patients with impaired liver function

Higher doses of phenylephrine may be needed in patients with cirrhosis of the liver.

Use in older people

Treatment in older people should be carried out with care.

Use in children

It is not recommended for use in children due to insufficient data on efficacy, safety and dosage recommendations.

If you use more Phenylephrine than you should

Signs that indicates that you have received too much Phenylephrine is a faster and irregular heart beat, headache, nausea, vomiting, paranoid psychosis, hallucinations and hypertension. It is unlikely that this will happen because you will get this medicine at a hospital.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following adverse reactions have been reported:

Some side effects may be serious. Tell your doctor straight away if you get any of the following:

  • chest pain or pain due to the angina
  • irregular heartbeat
  • feeling the heart pumping in the chest
  • bleeding in the brain (speech disorder, dizziness, paralysis of one side of the body)
  • psychosis (loosing contact with reality)

Other side effects may include (frequencies are not known):

  • reaction of hypersensitivity (allergy)
  • excessive dilation of the pupils
  • increased pressure in the eye (aggravation of glaucoma)
  • excitability (excessive sensitivity of an organ or body part)
  • agitation (restlessness)
  • anxiety
  • confusion
  • headache
  • nervousness,
  • insomnia (difficulty falling or staying asleep)
  • shaking (tremor)
  • burning of the skin
  • prickling of the skin
  • itching or tingling skin sensation (paraesthesia)
  • slow or high heart rate
  • high blood pressure
  • difficulty in breathing
  • fluids in the lung
  • nausea
  • vomiting
  • sweating
  • pallor or skin blanching (pale colour of the skin)
  • goose flesh
  • tissue damage at the site of the injection
  • muscle weakness
  • difficulty in passing urine or urine retention

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: Website: www.mhra.gov.uk/yellowcard

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Phenylephrine

Keep the ampoules in the outer carton in order to protect from light.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Phenylephrine contains

  • The active substance is phenylephrine as phenylephrine hydrochloride 0.1 mg/ml
  • The other ingredients are sodium chloride, sodium citrate, citric acid, water for injection and hydrochloric acid and sodium hydroxid for pH adjustment.

What Phenylephrine looks like and contents of the pack

Clear and colourless solution.

Phenylephrine 0.1 mg/ml, solution for injection, is available in glass ampoules of 5 ml and 10 ml.

The ampoules are packaged in trays of plastic and then in cartons of 5, 10, 20, 50 and 100 ampoules.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Unimedic Pharma AB

PO Box 6216

SE-102 34 Stockholm

Sweden

Manufacturer

Unimedic AB

Storjordenvägen 2

SE-864 31 Matfors Sweden

This leaflet was last revised in April 2021.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 50604/0002

Last revision stated in the text: April 2021 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Phenylephrine 0.1 mg/ml, solution for injection

Active substance Phenylephrine
Strength 0.1 mg/ml
Pharmaceutical form Clear, colourless solution with an osmolality of 270-300 mOsm/kg.
pH: 4,5-6,5.
Excipients Sodium chloride, sodium citrate, citric acid, water for injection and hydrochloride acid and sodium hydroxide for pH adjustment.
Shelf life 2 years
Storage Keep the ampoules in the outer carton in order to protect from light.
Drug group (ATC) Adrenergic- and dopaminergic drugs
  1. C Cardiovascular system drugs
    1. C01 Cardiac therapy drugs
      1. C01C Cardiac stimulants excl. cardiac glycosides
        1. C01CA Adrenergic and dopaminergic cardiac stimulants
          1. C01CA06 phenylephrine
Marketing authorisation PL 50604/0002 (first authorised 9 April 2025)
Marketing authorisation holder Unimedic Pharma AB

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.